Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
JMIR Dermatol ; 7: e40819, 2024 05 21.
Article in English | MEDLINE | ID: mdl-38772024

ABSTRACT

This study underscores the persistent underrepresentation of women in academic dermatology leadership positions by examining the gender composition of editorial boards across top dermatology journals, emphasizing the urgent need for proactive strategies to promote diversity, equity, and inclusion.


Subject(s)
Dermatology , Periodicals as Topic , Humans , Cross-Sectional Studies , Periodicals as Topic/statistics & numerical data , Female , Male , Physicians, Women/statistics & numerical data , Leadership , Editorial Policies , Gender Equity
2.
Microbiol Resour Announc ; 12(7): e0046323, 2023 Jul 18.
Article in English | MEDLINE | ID: mdl-37318351

ABSTRACT

Staphylococcus epidermidis is a ubiquitous skin commensal that has the potential to become pathogenic and cause disease. Here, we report the complete genome sequence of a S. epidermidis strain isolated from adult healthy skin that shows high expression of the virulence factor extracellular cysteine protease A (EcpA).

5.
Biometals ; 32(6): 845-859, 2019 12.
Article in English | MEDLINE | ID: mdl-31542844

ABSTRACT

Pancreatic beta cells produce and release insulin, a hormone that regulates blood glucose levels, and their dysfunction contributes to the development of diabetes mellitus. Zinc deficiency and inorganic arsenic exposure both independently associate with the development of diabetes, although the effects of their combination on pancreatic beta cell health and function remain unknown. We hypothesized zinc deficiency increases the toxicity associated with arsenic exposure, causing an increased susceptibility to DNA damage and disruption of insulin production. Zinc deficiency decreased cell proliferation by 30% in pancreatic INS-1 rat insulinoma cells. Arsenic exposure (0, 50 or 500 ppb exposures) significantly decreased cell proliferation, and increased mRNA levels of genes involved in stress response (Mt1, Mt2, Hmox1) and DNA damage (p53, Ogg1). When co-exposed to both zinc deficiency and arsenic, zinc deficiency attenuated this response to arsenic, decreasing the expression of Mt1, Hmox1, and Ogg1, and significantly increasing DNA double-strand breaks 2.9-fold. Arsenic exposure decreased insulin expression, but co-exposure did not decrease insulin levels beyond the arsenic alone condition, but did result in a further 33% decline in cell proliferation at the 500 ppb arsenic dose, and a significant increase in beta cell apoptosis. These results suggest zinc deficiency and arsenic, both independently and in combination, adversely affect pancreatic beta cell health and both factors should be considered in the evaluation of health outcomes for susceptible populations.


Subject(s)
Arsenic/toxicity , Insulin-Secreting Cells/drug effects , Zinc/deficiency , Animals , Apoptosis/drug effects , Arsenic/pharmacology , Cells, Cultured , DNA Breaks, Double-Stranded , Rats , Zinc/analysis
SELECTION OF CITATIONS
SEARCH DETAIL